Tardive Dyskinesia Risks and Metoclopramide Use Before and After U.S. Market Withdrawal of Cisapride
- 1 November 2004
- journal article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 44 (6) , 661-665
- https://doi.org/10.1331/1544345042467191
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Tardive dyskinesia associated with metoclopramide in persons with developmental disabilitiesResearch in Developmental Disabilities, 2002
- Antipsychotic-Induced Movement Disorders in the ElderlyDrugs & Aging, 2000
- Drug-Induced Movement DisordersDrug Safety, 1997
- Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesiaActa Psychiatrica Scandinavica, 1996
- Metoclopramide and Tardive DyskinesiaBiological Psychiatry, 1994
- Psychiatric Disorder and Disability in New Zealand Long-Stay Psychiatric PatientsAustralian & New Zealand Journal of Psychiatry, 1993
- Current outcome in schizophrenia: women vs menActa Psychiatrica Scandinavica, 1986
- Epidemiology of Tardive DyskinesiaClinical Neuropharmacology, 1983
- Tardive DyskinesiaArchives of General Psychiatry, 1982
- Overview: public health issues in tardive dyskinesiaAmerican Journal of Psychiatry, 1980